Estrella Immunopharma appoints Jia Dengyao to Board of Directors

Estrella Immunopharma, Inc.

Board appointed Jia Dengyao as director effective September 22, 2025.
Mr. Jia has not been named to any Board committees as of the filing.
Company entered into standard indemnification agreement with new director.
Appointment adds a new independent voice but no other details provided.

item 5.02

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-092471

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.